Since previous research has implicated FGFR4 in prostate cancer progression, we sought to examine the effect of FGFR4 activation on NFκB signaling in DU145 prostate cancer cells [9], [10], known to express high levels of endogenous FGFR4 [29]. The gene discussed is FGFR4; the disease is prostate carcinoma.